13 Flashcards

1
Q

what does AIRE do

A

allows mTECs to express, process and present peripheral antigens so that you have central positive selection of autoreactive T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what does a mutated AIRE lead to

A

autoimmune polyendoriconicopathy syndrome APECED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what happens if there is little to no aire activity

A

little to no expression of peripheral antigesn by mTECs, no central negative sleection of autoreactive T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what happens to high but not very high TCR affinity for self

A

some devleop into T regs that are CD4+

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

positive selection on

A

cTECs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

negative selection on

A

mTECs and thymic dentdritic cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

where do superantigens come from

A

bacteria or viruses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what do superantigens activate

A

5% of all T cells in periphery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what do superantigens induce

A

severe negative selection/ massive deletion in thymus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

when do gamma delta T cells develop

A

earlier than aB T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

numbers of gamma delta T cells

A

lower than aB T cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

where are gammma delta T cellls found

A

in skin and epithelial areas like lungs and intestines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

what do gamma delta T cells respond to

A

narrrow range of protein antigens and are the first line of defense for invading pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

variability of gamma delta T cells

A

less variable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

correlates of protection

A

aspects of immunity assocaitedd with protection from infection or protection from disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is needed to know when making a vaccine

A

what type of imunity is needed for the specific pathogen

aB OR CELL MEDIATED

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

what immunity is required for viruses

A

both antibody and cell mediated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what does vaccination do to infection or sickness

A

protects from disaese without infection or sickness

leads to herd immunity to protect unvaccinated

activates specific parts of the immune system responsible for protection of infcetion from the disease (correlates of protection)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is cross presentation

A

Cross-presentation is the ability of certain professional antigen-presenting cells to take up, process and present extracellular antigens with MHC class I molecules to CD8 T cells

20
Q

when should you induce the B cell correlate of protection

A
  • Ab neutralization
    -opsonization
    -metabolic interference

-needs to be directed against an external part of the pathogen

21
Q

when should you induce the B cell correlate of protection

A

-cytokine production
-B cell help
-direct killing of infected cells

-more effective at recognizing pathogens with restricted diversity
-can use internal and external components bc antigens are processesd and presented

22
Q

what is the process of vaccine production

A

pre clinial

acceptance to test on humans

phase i - 20-80 ppl
testing safety

phase ii- 100-300 ppl
safety and effectiveness

phase iii- 1000-3000 ppl
safety and effectiveness in large population

FDA reivew approval for mass public

phase 4- will see rare effects
post marketting surveilence

23
Q

when are rare events detected for vaccines

A

phase 4 which is why we need post marketing surveilence

24
Q

EUA

A

emergency usage approval - 2 months

25
full approval
6 months
26
what are adjuvants
increase immunogenicity only needed for some times of vaccines
27
stabilizers
maintain effectiveness and structure durign transport and sorage
28
carry over substances
cause allergies from manufacturing
29
what are the components of an effective vaccine
antigen packaging of antigen - only some vaccines need this adjuvants stabilizers carry over from manufacturing
30
antigen
whole organism or select genes/prtoeins
31
antigen for covid
spike protein
32
antigen for influenza
HA protein
33
tetanus antigen
toxoid
34
pneumococcal pneumonia antigen
capsular polysaccharide
35
what are the mechanisms for adjuvant function
slow antigen release from site of injection recruit leukocytes- proinflamatory cytokines and chemokines- encourage thier maturation and migration (actiavion and trafficking to draining lymph nodes of pAPC) aggregate adjuvants to encourage phagocytosis by local apcs upregulate MHCII and costimulatory molecules to facilitate antigen presentation
36
what kind of vaccines lead to cell mediated cytotoxicity and ab respnose
endogenous pathway live attenuated viral vector mRNA subunit depending on packaging
37
what types of vaccines only get an antibody resposne
whole inactivated virus like paricle recombinant viral particles subnunit conugate
38
live attentuated respone
ab and cell mediated
39
virus like particles response
ab mediated
40
subunit
depends on packaging but can be both
41
mRNA response
ab and cell mediated
42
conjugae response
ab
43
viral recombinant particles
ab
44
viral like particles
ab
45
viral vector
ab and cell mediated
46